Abstract
The binding of [3H]citalopram to the platelet 5-hydroxytryptamine (5-HT) transporter was measured in a group of healthy male drinkers ofayahuasca, a psychoactive sacrament indigenous to Amazonia, and a group healthy male controls. An increased number of binding sites (Bmax) in the platelets of ayahuasca drinkers was found, while the dissociation constant (Kd) remained the same for both groups. If indicative of neuronal 5-HT uptake activity, these results would suggest a decreased concentration of extracellular 5-HT, or a response to increased production and release of 5-HT. Such changes in 5-HT synaptic activity, in this case, should not be misinterpreted as an indication of developing neurological or psychiatric illness.
This is a preview of subscription content, log in via an institution to check access.
References
Airaksinen MM, Kari I (1991)β-Carbolines, psychoactive compounds in the mammalian body. Part II. Med Biol 59:190–211
Airaksinen MM, Svensk H, Tuomisto J, Komulainen H (1980) Tetrahydro-β-carbolines and corresponding tryptamines: In vivo inhibition of serotonin and dopamine uptake by human blood platelets. Acta Pharmacol Toxicol 46:308–313.
Airaksinen MM, Callaway JC, Rägo L, Nykvist P, Kari E, Gynther J (1993) Binding sites for [3H]pinoline. In: Touitou Y, Arendt J, Pévet P (eds) Melatonin and the pineal gland: From basic science to clinical application (International Congress Series 1017). Elsevier Science Publishers BV, Excerpta Medica, Amsterdam London New York Tokyo, pp 83–86
Graham D, Tahraoui L, Langer AZ (1987) Effect of chronic treatment with selective monoamine oxidase inhibitors and specific 5-hydroxytryptamine uptake inhibitors on [3H]paroxetine binding to cerebral cortical membranes of the rat. Neuropharmacology 26:1087–1092
Hrinda PD (1987) Regulation of high- and low-affinity [3H]imipramine sites in rat brain by chronic treatment with antidepressants. Eur J Pharmacol 138:159–168.
Lesch KP, Aulakh CS, Wolozin BL, Tolliver TJ, Hill JL, Murphy DL (1993) Regional brain expression of serotonin transporter mRNA and its regulation by reuptake inhibiting antidepressants. Mol Brain Res 17:31–35.
Luna LE, Amaringo PC (1991) Ayahuasca visions: The religious iconography of a Peruvian shaman. North Atlantic Books, Berkeley
Marazziti D, Falcone M, Rotondo A, Castrogiovanni P (1989) Age-related differences in human platelet 5-HT uptake. Naunyn-Schmiedeberg's Arch Pharmacol 340:593–594
Marcusson JO, Ross SB (1990) Binding of some antidepressants to the 5-hydroxytryptamine transporter in brain and platelets. Psychopharmacology 102:145–155
Ott J (1994) Ayahuasca analogues: Pangæn entheogens. Natural Products Co., Kennewick, Wash.
Plenge P, Mellerup ET (1991) [3H]Citalopram binding to brain and platelet membranes of human and rat. J Neurochem 56:248–252
Räisänen M, Kärkkäinen J (1979) Mass fragmentographic quantification of urinaryN,N-dimethyltryptamine and bufotenine. J Chromatogr Biomed Appl 162:579–584
Rocca P, Galzin A-M, Langer SZ (1989) Light-dark differences in [3H]paroxetine binding to rabbit platelet membranes. Naunyn-Schmiedeberg's Arch Pharmacol 340:41–44
Spurlock G, Buchland P, O'Donovan H, McGuffin P (1994) Lack of effect of antidepressant drugs on the levels of mRNAs encoding serotonergic receptors, synthetic enzymes and 5HT transporter. Neuropharmacology 33 (3/4):433–440
Strassman RJ (1992) Human hallucinogen interactions with drugs affecting serotonergic neurotransmission. Neuropsychopharmacology 7:241–243
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Callaway, J.C., Airaksinen, M.M., McKenna, D.J. et al. Platelet serotonin uptake sites increased in drinkers ofayahuasca . Psychopharmacology 116, 385–387 (1994). https://doi.org/10.1007/BF02245347
Issue Date:
DOI: https://doi.org/10.1007/BF02245347